| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine and Hematology/Oncology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
Correspondence: Michael L. Grossbard, M.D., Hematology/Oncology Unit, Massachusetts General Hospital, Cox 315, 100 Blossom Street, Boston, MA 02114, USA. Telephone: 617-724-1134; Fax: 617-724-1137; e-mail: GrossbardM{at}A1.MGH.HARVARD.EDU
Approximately 3,500 cases of stage I and II Hodgkins disease are diagnosed each year in the United States. Traditionally, those patients who are considered candidates for primary radiation therapy undergo staging laparotomy (pathologic staging) to rule out definitively the presence of occult subdiaphragmatic disease. An appreciation of the risks of laparotomy and a recognition of the effectiveness of salvage chemotherapy in patients who fail primary radiation therapy have permitted the increased use of clinical staging as the basis for treatment of these patients. This article summarizes the literature regarding the need for staging laparotomy in early stage Hodgkins disease and suggests alternative approaches to the management of these patients based on clinical criteria and prognostic factors.
This article has been cited by other articles:
![]() |
A. T. Lefor Laparoscopic Interventions in Lymphoma Management Surgical Innovation, June 1, 2000; 7(2): 129 - 139. [Abstract] [PDF] |
||||
![]() |
U. Baccarani, B. J. Carroll, J. R. Hiatt, A. Donini, G. Terrosu, R. Decker, M. Chandra, F. Bresadola, and E. H. Phillips Comparison of Laparoscopic and Open Staging in Hodgkin Disease Arch Surg, May 1, 1998; 133(5): 517 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Cho, B. H. Levinson, and E. Glatstein To Lap or Not to Lap Oncologist, June 1, 1996; 1(3): 120 - 124. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |